We are live on ! Find out more
NYMX

Nymox Pharmaceutical Corp
NYMX

Delisted

NYMX was delisted on the 6th of July, 2023.

Back to rankings

63 hedge funds and large institutions have $19.9M invested in Nymox Pharmaceutical Corp in 2020 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 12 increasing their positions, 11 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

813% more call options, than puts

Call options by funds: $621K | Put options by funds: $68K

214% more capital invested

Capital invested by funds: $6.32M → $19.9M (+$13.6M)

200% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 8

34% more funds holding

Funds holding: 47 → 63 (+16)

9% more repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 11

Holders
63
Holders Change
+16
Holders Change %
+34.04%
% of All Funds
1.29%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
24
Increased
12
Reduced
11
Closed
8
Calls
$621K
Puts
$68K
Net Calls
+$553K
Net Calls Change
+$567K

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$5.53M
2
State Street
State Street
Massachusetts
+$1.33M
3
Northern Trust
Northern Trust
Illinois
+$1.29M
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$769K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$507K

Top Sellers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$999K
2
Millennium Management
Millennium Management
New York
-$909K
3
Goldman Sachs
Goldman Sachs
New York
-$433K
4
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT)
United Kingdom
-$156K
5
Renaissance Technologies
Renaissance Technologies
New York
-$143K
Name Holding Trade Value Shares
Change 		Change in
Stake
Wolverine Trading
51
Wolverine Trading
Illinois
$36K -$1.3K -412 -4%
Royal Bank of Canada
52
Royal Bank of Canada
Ontario, Canada
$25K – – –
Legal & General Group
53
Legal & General Group
United Kingdom
$22K +$20K +6,317 New
Citigroup
54
Citigroup
New York
$18K -$53.1K -16,788 -76%
BWA
55
BDO Wealth Advisors
Florida
$17K – – –
Simplex Trading
56
Simplex Trading
Illinois
$14K -$13.2K -4,185 -51%
Bank of Montreal
57
Bank of Montreal
Ontario, Canada
$12K +$10.2K +3,210 +973%
AIP
58
Ameritas Investment Partners
Nebraska
$12K +$11K +3,482 New
LIA
59
LS Investment Advisors
Michigan
$11K – – –
SIAP
60
Sterling Investment Advisors (Pennsylvania)
Pennsylvania
$8K – – –
BNP Paribas Financial Markets
61
BNP Paribas Financial Markets
France
$5.29K +$4.12K +1,304 +705%
ClearBridge Investments
62
ClearBridge Investments
New York
$4K – – –
Group One Trading
63
Group One Trading
Illinois
$2K -$15.8K -5,000 -89%
Millennium Management
64
Millennium Management
New York
– -$909K -388,656 Closed
Qube Research & Technologies (QRT)
65
Qube Research & Technologies (QRT)
United Kingdom
– -$156K -66,800 Closed
ECM
66
ExodusPoint Capital Management
New York
– -$132K -56,618 Closed
JG
67
Jefferies Group
New York
– -$34K -14,600 Closed
PP
68
Paloma Partners
Connecticut
– -$31K -13,154 Closed
HighTower Advisors
69
HighTower Advisors
Illinois
– -$28K -12,000 Closed
SM
70
Sciencast Management
New Jersey
– -$23K -10,568 Closed
PP
71
Pacifica Partners
Canada
– -$3K -1,406 Closed
1 2
3

NYMX Hedge Fund Activity: Q2 2020 in Review

63 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in Nymox Pharmaceutical Corp (NYMX) for Q2 2020, worth a combined $19.9M — up 214% from $6.32M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new NYMX positions and 8 closed out — a net gain of 16 holders — while 12 added to existing stakes and 11 trimmed.

The largest buyer was BlackRock, adding an estimated $5.53M. The largest seller was Susquehanna International Group, cutting an estimated $999K.

  • 63 institutional investors held Nymox Pharmaceutical Corp (NYMX) as of Q2 2020, up from 47 in Q1 2020.
  • Funds reported $19.9M of Nymox Pharmaceutical Corp stock for Q2 2020, up 214% quarter-over-quarter.
  • 24 funds opened new Nymox Pharmaceutical Corp positions in Q2 2020 and 8 closed out, a net change of +16 holders.
  • The largest Nymox Pharmaceutical Corp buyer in Q2 2020 was BlackRock, an estimated $5.53M added.
  • The largest Nymox Pharmaceutical Corp seller in Q2 2020 was Susquehanna International Group, an estimated $999K sold.

Based on aggregated 13F filings for Q2 2020.